Moccia, A. A., Schaff, K., Freeman, C., Hoskins, P. J., Klasa, R. J., Savage, K. J., . . . Sehn, L. H. (2021). Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines. Blood Adv.
Citação norma ChicagoMoccia, Alden A., et al. "Long-term Outcomes of R-CEOP Show Curative Potential in Patients With DLBCL and a Contraindication to Anthracyclines." Blood Adv 2021.
MLA引文Moccia, Alden A., et al. "Long-term Outcomes of R-CEOP Show Curative Potential in Patients With DLBCL and a Contraindication to Anthracyclines." Blood Adv 2021.
警告:這些引文格式不一定是100%准確.